Medicinova Inc financial data

Symbol
MNOV on Nasdaq
Location
4275 Executive Square, Suite 300, La Jolla, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.78K % +6.52%
Debt-to-equity 5.49 % -5.99%
Return On Equity -13.4 % +25.8%
Return On Assets -12.7 % +25.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49M shares 0%
Common Stock, Shares, Outstanding 49M shares 0%
Entity Public Float 109M USD -6.9%
Common Stock, Value, Issued 49K USD 0%
Weighted Average Number of Shares Outstanding, Basic 49M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 49M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1M USD
Research and Development Expense 5.5M USD -23.6%
General and Administrative Expense 4.95M USD -13.4%
Operating Income (Loss) -9.82M USD +26.7%
Net Income (Loss) Attributable to Parent -8.16M USD +34.4%
Earnings Per Share, Basic -0.16 USD/shares +38.5%
Earnings Per Share, Diluted -0.16 USD/shares +38.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 44.3M USD -16.1%
Accounts Receivable, after Allowance for Credit Loss, Current 1M USD
Assets, Current 45.5M USD -15%
Property, Plant and Equipment, Net 35.8K USD -34.4%
Operating Lease, Right-of-Use Asset 443K USD -33.8%
Goodwill 9.6M USD 0%
Other Assets, Noncurrent 19K USD -73.9%
Assets 60.4M USD -12.1%
Accounts Payable, Current 668K USD +21.8%
Employee-related Liabilities, Current 824K USD -10.4%
Liabilities, Current 2.49M USD -11.6%
Deferred Income Tax Liabilities, Net 202K USD 0%
Operating Lease, Liability, Noncurrent 302K USD -41.8%
Other Liabilities, Noncurrent 302K USD -41.8%
Liabilities 3M USD -15.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -132K USD -8.66%
Retained Earnings (Accumulated Deficit) -421M USD -1.98%
Stockholders' Equity Attributable to Parent 57.4M USD -11.9%
Liabilities and Equity 60.4M USD -12.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.87M USD -21.7%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 49M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.86M USD -111%
Deferred Tax Assets, Valuation Allowance 83.4M USD +1.22%
Deferred Tax Assets, Gross 84.7M USD +1.19%
Operating Lease, Liability 493K USD -31.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -8.18M USD +34.3%
Lessee, Operating Lease, Liability, to be Paid 557K USD -34.1%
Property, Plant and Equipment, Gross 489K USD +2.35%
Operating Lease, Liability, Current 190K USD -5.58%
Lessee, Operating Lease, Liability, to be Paid, Year Two 206K USD -9.71%
Lessee, Operating Lease, Liability, to be Paid, Year One 223K USD -15.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 64.5K USD -47.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 17.3K USD -91.6%
Deferred Tax Assets, Operating Loss Carryforwards 70M USD -0.23%
Unrecognized Tax Benefits 1.59M USD +77.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 17.3K USD -91.6%
Operating Lease, Payments 257K USD +0.39%
Depreciation, Depletion and Amortization 5.35K USD +30.3%
Share-based Payment Arrangement, Expense 405K USD -60.2%